Cell-autonomous intracellular androgen receptor signaling drives the growth of human prostate cancer initiating cells

Donald J. Vander Griend, Jason D'Antonio, Bora Gurel, Lizamma Antony, Angelo Michael Demarzo, John Tod Isaacs

Research output: Contribution to journalArticle

Abstract

BACKGROUND. The lethality of prostate cancer is due to the continuous growth of cancer initiating cells (CICs) which are often stimulated by androgen receptor (AR) signaling. However, the underlying molecular mechanism(s) for such AR-mediated growth stimulation are not fully understood. Such mechanisms may involve cancer cell-dependent induction of tumor stromal cells to produce paracrine growth factors or could involve cancer cell autonomous autocrine and/or intracellular AR signaling pathways. METHODS. We utilized clinical samples, animal models and a series of AR-positive human prostate cancer cell lines to evaluate AR-mediated growth stimulation of prostate CICs. RESULTS. The present studies document that stromal AR expression is not required for prostate cancer growth, since tumor stroma surrounding AR-positive human prostate cancer metastases (N = 127) are characteristically AR-negative. This lack of a requirement for AR expression in tumor stromal cells is also documented by the fact that human AR-positive prostate cancer cells grow equally well when xenografted in wild-type versus AR-null nude mice. AR-dependent growth stimulation was documented to involve secretion, extracellular binding, and signaling by autocrine growth factors. Orthotopic xenograft animal studies documented that the cellautonomous autocrine growth factors which stimulate prostate CIC growth are not the andromedins secreted by normal prostate stromal cells. Such cell autonomous and extracellular autocrine signaling is necessary but not sufficient for the optimal growth of prostate CICs based upon the response to anti-androgen plus/or minus preconditioned media. CONCLUSIONS. AR-induced growth stimulation of human prostate CICs requires AR-dependent intracellular pathways. The identification of such AR-dependent intracellular pathways offers new leads for the development of effective therapies for prostate cancer.

Original languageEnglish (US)
Pages (from-to)90-99
Number of pages10
JournalProstate
Volume70
Issue number1
DOIs
StatePublished - Jan 1 2010

Fingerprint

Androgen Receptors
Prostatic Neoplasms
Growth
Stromal Cells
Autocrine Communication
Neoplasms
Intercellular Signaling Peptides and Proteins
Heterografts
Nude Mice
Androgens
Prostate
Animal Models
Neoplasm Metastasis

Keywords

  • Androgen receptor
  • Cancer initiating cell
  • Human prostate cancer
  • Oncogene

ASJC Scopus subject areas

  • Urology
  • Oncology

Cite this

Cell-autonomous intracellular androgen receptor signaling drives the growth of human prostate cancer initiating cells. / Vander Griend, Donald J.; D'Antonio, Jason; Gurel, Bora; Antony, Lizamma; Demarzo, Angelo Michael; Isaacs, John Tod.

In: Prostate, Vol. 70, No. 1, 01.01.2010, p. 90-99.

Research output: Contribution to journalArticle

Vander Griend, Donald J. ; D'Antonio, Jason ; Gurel, Bora ; Antony, Lizamma ; Demarzo, Angelo Michael ; Isaacs, John Tod. / Cell-autonomous intracellular androgen receptor signaling drives the growth of human prostate cancer initiating cells. In: Prostate. 2010 ; Vol. 70, No. 1. pp. 90-99.
@article{405b46f5c9e64e59b302a42eb63a0dda,
title = "Cell-autonomous intracellular androgen receptor signaling drives the growth of human prostate cancer initiating cells",
abstract = "BACKGROUND. The lethality of prostate cancer is due to the continuous growth of cancer initiating cells (CICs) which are often stimulated by androgen receptor (AR) signaling. However, the underlying molecular mechanism(s) for such AR-mediated growth stimulation are not fully understood. Such mechanisms may involve cancer cell-dependent induction of tumor stromal cells to produce paracrine growth factors or could involve cancer cell autonomous autocrine and/or intracellular AR signaling pathways. METHODS. We utilized clinical samples, animal models and a series of AR-positive human prostate cancer cell lines to evaluate AR-mediated growth stimulation of prostate CICs. RESULTS. The present studies document that stromal AR expression is not required for prostate cancer growth, since tumor stroma surrounding AR-positive human prostate cancer metastases (N = 127) are characteristically AR-negative. This lack of a requirement for AR expression in tumor stromal cells is also documented by the fact that human AR-positive prostate cancer cells grow equally well when xenografted in wild-type versus AR-null nude mice. AR-dependent growth stimulation was documented to involve secretion, extracellular binding, and signaling by autocrine growth factors. Orthotopic xenograft animal studies documented that the cellautonomous autocrine growth factors which stimulate prostate CIC growth are not the andromedins secreted by normal prostate stromal cells. Such cell autonomous and extracellular autocrine signaling is necessary but not sufficient for the optimal growth of prostate CICs based upon the response to anti-androgen plus/or minus preconditioned media. CONCLUSIONS. AR-induced growth stimulation of human prostate CICs requires AR-dependent intracellular pathways. The identification of such AR-dependent intracellular pathways offers new leads for the development of effective therapies for prostate cancer.",
keywords = "Androgen receptor, Cancer initiating cell, Human prostate cancer, Oncogene",
author = "{Vander Griend}, {Donald J.} and Jason D'Antonio and Bora Gurel and Lizamma Antony and Demarzo, {Angelo Michael} and Isaacs, {John Tod}",
year = "2010",
month = "1",
day = "1",
doi = "10.1002/pros.21043",
language = "English (US)",
volume = "70",
pages = "90--99",
journal = "Prostate",
issn = "0270-4137",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Cell-autonomous intracellular androgen receptor signaling drives the growth of human prostate cancer initiating cells

AU - Vander Griend, Donald J.

AU - D'Antonio, Jason

AU - Gurel, Bora

AU - Antony, Lizamma

AU - Demarzo, Angelo Michael

AU - Isaacs, John Tod

PY - 2010/1/1

Y1 - 2010/1/1

N2 - BACKGROUND. The lethality of prostate cancer is due to the continuous growth of cancer initiating cells (CICs) which are often stimulated by androgen receptor (AR) signaling. However, the underlying molecular mechanism(s) for such AR-mediated growth stimulation are not fully understood. Such mechanisms may involve cancer cell-dependent induction of tumor stromal cells to produce paracrine growth factors or could involve cancer cell autonomous autocrine and/or intracellular AR signaling pathways. METHODS. We utilized clinical samples, animal models and a series of AR-positive human prostate cancer cell lines to evaluate AR-mediated growth stimulation of prostate CICs. RESULTS. The present studies document that stromal AR expression is not required for prostate cancer growth, since tumor stroma surrounding AR-positive human prostate cancer metastases (N = 127) are characteristically AR-negative. This lack of a requirement for AR expression in tumor stromal cells is also documented by the fact that human AR-positive prostate cancer cells grow equally well when xenografted in wild-type versus AR-null nude mice. AR-dependent growth stimulation was documented to involve secretion, extracellular binding, and signaling by autocrine growth factors. Orthotopic xenograft animal studies documented that the cellautonomous autocrine growth factors which stimulate prostate CIC growth are not the andromedins secreted by normal prostate stromal cells. Such cell autonomous and extracellular autocrine signaling is necessary but not sufficient for the optimal growth of prostate CICs based upon the response to anti-androgen plus/or minus preconditioned media. CONCLUSIONS. AR-induced growth stimulation of human prostate CICs requires AR-dependent intracellular pathways. The identification of such AR-dependent intracellular pathways offers new leads for the development of effective therapies for prostate cancer.

AB - BACKGROUND. The lethality of prostate cancer is due to the continuous growth of cancer initiating cells (CICs) which are often stimulated by androgen receptor (AR) signaling. However, the underlying molecular mechanism(s) for such AR-mediated growth stimulation are not fully understood. Such mechanisms may involve cancer cell-dependent induction of tumor stromal cells to produce paracrine growth factors or could involve cancer cell autonomous autocrine and/or intracellular AR signaling pathways. METHODS. We utilized clinical samples, animal models and a series of AR-positive human prostate cancer cell lines to evaluate AR-mediated growth stimulation of prostate CICs. RESULTS. The present studies document that stromal AR expression is not required for prostate cancer growth, since tumor stroma surrounding AR-positive human prostate cancer metastases (N = 127) are characteristically AR-negative. This lack of a requirement for AR expression in tumor stromal cells is also documented by the fact that human AR-positive prostate cancer cells grow equally well when xenografted in wild-type versus AR-null nude mice. AR-dependent growth stimulation was documented to involve secretion, extracellular binding, and signaling by autocrine growth factors. Orthotopic xenograft animal studies documented that the cellautonomous autocrine growth factors which stimulate prostate CIC growth are not the andromedins secreted by normal prostate stromal cells. Such cell autonomous and extracellular autocrine signaling is necessary but not sufficient for the optimal growth of prostate CICs based upon the response to anti-androgen plus/or minus preconditioned media. CONCLUSIONS. AR-induced growth stimulation of human prostate CICs requires AR-dependent intracellular pathways. The identification of such AR-dependent intracellular pathways offers new leads for the development of effective therapies for prostate cancer.

KW - Androgen receptor

KW - Cancer initiating cell

KW - Human prostate cancer

KW - Oncogene

UR - http://www.scopus.com/inward/record.url?scp=72849129206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72849129206&partnerID=8YFLogxK

U2 - 10.1002/pros.21043

DO - 10.1002/pros.21043

M3 - Article

C2 - 19790235

AN - SCOPUS:72849129206

VL - 70

SP - 90

EP - 99

JO - Prostate

JF - Prostate

SN - 0270-4137

IS - 1

ER -